Zepp Health (ZEPP) Gains from Sales and Divestitures (2016 - 2025)

Zepp Health (ZEPP) has reported Gains from Sales and Divestitures for 9 consecutive years, with $1.5 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Gains from Sales and Divestitures changed N/A year-over-year to $1.5 million; the TTM figure through Dec 2025 stood at $1.5 million (changed N/A YoY), while the FY2025 annual figure was $1.5 million, changed N/A from the prior year.
• Gains from Sales and Divestitures came in at $1.5 million for Q4 2025 at Zepp Health, up from $224537.0 in the prior quarter.
• The five-year high for Gains from Sales and Divestitures was $1.5 million in Q4 2025, with the low at $80968.1 in Q4 2021.
• Average Gains from Sales and Divestitures over 4 years is $489006.1, with a median of $201440.2 recorded in 2022.
• Across the five-year window, Gains from Sales and Divestitures plunged 45.63% in 2021 and surged 120.26% in 2022, its largest moves.
• Year by year, Gains from Sales and Divestitures stood at $80968.1 in 2021, then soared by 120.26% to $178343.3 in 2022, then grew by 25.9% to $224537.0 in 2023, then soared by 555.65% to $1.5 million in 2025.
• According to Business Quant data, Gains from Sales and Divestitures over the past three periods registered $1.5 million, $224537.0, and $178343.3 for Q4 2025, Q4 2023, and Q4 2022 respectively.